StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Regeneron (REGN)

Regeneron (REGN) COVID-19 Antibody Cocktail Prevented 100% of Symptomatic Infections When Used as Passive Vaccine January 26, 2021 7:01 AM - StreetInsider Regeneron Reports Positive Interim Data with REGEN-COV™ Antibody Cocktail used as Passive Vaccine to Prevent COVID-19 January 26, 2021 7:00 AM - PR NewsWire UPDATE: BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform January 25, 2021 12:07 AM - StreetInsider Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021 January 21, 2021 12:01 PM - PR NewsWire Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021 January 21, 2021 12:00 PM - PR NewsWire Regeneron to Report Fourth Quarter and Full Year 2020 Financial and Operating Results and Host Conference Call and Webcast on February 5, 2021 January 19, 2021 4:15 PM - PR NewsWire Regeneron Pharma (REGN) PT Raised to $553 at Morgan Stanley January 19, 2021 2:35 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Jan 12 January 15, 2021 4:02 PM - SEC Filing Benchmark Upgrades Regeneron Pharma (REGN) to Buy January 13, 2021 4:51 AM - StreetInsider Regeneron (REGN) Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses January 12, 2021 5:45 PM - StreetInsider Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses January 12, 2021 5:45 PM - PR NewsWire Regeneron Pharma (REGN) Thoughts After Speaking with Management - Truist Securities January 12, 2021 6:52 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Jan 11 January 11, 2021 6:04 AM - SEC Filing Citi Upgrades Regeneron Pharma (REGN) to Buy January 8, 2021 5:09 AM - StreetInsider Arthritis Drugs Reduce Covid-19 Deaths, ICU Time in Study - Bloomberg January 7, 2021 11:02 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: BROWN MICHAEL S January 5, 2021 4:54 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: SING GEORGE L January 5, 2021 4:34 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: Zoghbi Huda Y January 5, 2021 4:12 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: POON CHRISTINE A January 5, 2021 4:12 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: Tessier-Lavigne Marc January 5, 2021 4:12 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: COLES N ANTHONY January 5, 2021 4:12 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: Bassler Bonnie L January 5, 2021 4:11 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: RYAN ARTHUR F January 5, 2021 4:10 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Jan 04 Filed by: GOLDSTEIN JOSEPH L January 5, 2021 4:07 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 31 Filed by: YANCOPOULOS GEORGE January 5, 2021 4:05 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 31 Filed by: SCHLEIFER LEONARD S January 5, 2021 4:05 PM - SEC Filing Regeneron Pharma (REGN) PT Lowered to $595 at BofA Securities January 5, 2021 8:02 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Dec 31 January 5, 2021 7:51 AM - SEC Filing Truist Securities Reiterates Buy Rating on Regeneron Pharma (REGN) After Eylea Deemed Inapplicable for MFN Rule January 4, 2021 7:46 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Dec 30 Filed by: YANCOPOULOS GEORGE December 31, 2020 5:31 PM - SEC Filing CDC says COVID variants could reduce the efficacy of monoclonal antibodies, but unlikely to have a large impact on vaccine immunity - Bloomberg December 30, 2020 1:47 PM - StreetInsider Fresenius Medical Care (FMS) to being administering Eli Lilly & Co. (LLY), Regeneron (REGN) COVID-19 antibody drugs to kidney dialysis patients who tested positive - Reuters December 30, 2020 9:31 AM - StreetInsider Regeneron Pharma (REGN) Posts "Middle of the Road" Ph3 Data - RBC December 30, 2020 6:36 AM - StreetInsider Vertex (VRTX) Pipeline Looks Strong Enough to Justify Multiple Expansion in 2021 - Oppenheimer December 30, 2020 6:31 AM - StreetInsider Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen December 29, 2020 4:30 PM - PR NewsWire Regeneron (REGN) Reports Publication of Initial Clinical Data from Ongoing Ph. 1/2/3 Trial of Antibody Cocktail Casirivimab & Imdevimab in Non-Hospitalized Patients with COVID-19 December 17, 2020 5:03 PM - StreetInsider New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19 December 17, 2020 5:00 PM - PR NewsWire Regeneron Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference December 16, 2020 7:00 AM - PR NewsWire Regeneron Pharma (REGN) PT Lowered to $736 at Credit Suisse December 16, 2020 4:40 AM - StreetInsider Regeneron (REGN) IV flat as shares at lower end of five-month range December 16, 2020 4:33 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: MURPHY ANDREW J December 11, 2020 4:08 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: VAGELOS P ROY December 11, 2020 4:07 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: Van Plew Daniel P December 11, 2020 4:07 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: McCourt Marion December 11, 2020 4:06 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: STAHL NEIL December 11, 2020 4:06 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: Fenimore Christopher R. December 11, 2020 4:05 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: Landry Robert E December 11, 2020 4:04 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Dec 09 Filed by: LAROSA JOSEPH J December 11, 2020 4:04 PM - SEC Filing Regeneron (REGN) call put ratio 2.2 calls to 1 put into FDA panel votes on Pfizer’s (PFE) Covid vaccine December 10, 2020 10:01 AM - StreetInsider BofA Securities Sees Trading Opportunity in Regeneron Pharma (REGN) Ahead of ASH Presentation December 7, 2020 6:43 AM - StreetInsider Regeneron's BCMAxCD3 Bispecific Antibody (REGN5458) Shows Deep and Durable Responses in Patients with Heavily-pretreated Multiple Myeloma in Phase 1 December 5, 2020 5:00 PM - PR NewsWire Regeneron (REGN) Must Face Justice Department Lawsuit Citing Kickbacks - Bloomberg December 4, 2020 3:15 PM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Dec 01 Filed by: RYAN ARTHUR F December 2, 2020 4:10 PM - SEC Filing Regeneron Announces Investor Webcast at American Society of Hematology 2020 Annual Meeting November 30, 2020 7:00 AM - PR NewsWire Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis November 30, 2020 1:00 AM - StreetInsider Dupixent® (dupilumab) Approved by European Commission as First and Only Biologic Medicine for Children Aged 6 to 11 Years with Severe Atopic Dermatitis November 30, 2020 12:59 AM - PR NewsWire FDA Approves Regeneron's (REGN) Covid-19 Antibody Treatment, Impact on EPS Could Be 'Meaningful' November 23, 2020 8:56 AM - StreetInsider Regeneron Pharma (REGN) Cocktail EUA Widely Expected - Credit Suisse November 23, 2020 7:19 AM - StreetInsider Regeneron's (REGN) COVID-19 Antibody Cocktail REGEN-COV2 Receive FDA Emergency Use Authorization November 23, 2020 6:07 AM - StreetInsider Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization November 21, 2020 7:56 PM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Nov 16 Filed by: MURPHY ANDREW J November 18, 2020 4:03 PM - SEC Filing Regeneron says Roche successfully tested manufacture of COVID-19 drug used on Trump November 17, 2020 4:15 PM - StreetInsider U.S. hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply November 17, 2020 7:07 AM - StreetInsider Regeneron Included on Dow Jones Sustainability World Index for Second Consecutive Year November 16, 2020 7:00 AM - PR NewsWire Form 4 REGENERON PHARMACEUTICAL For: Nov 13 Filed by: COLES N ANTHONY November 13, 2020 5:58 PM - SEC Filing Regeneron Announces Investor Conference Presentations November 13, 2020 4:15 PM - PR NewsWire KeyBanc Starts Regeneron Pharma (REGN) at Overweight November 9, 2020 4:20 PM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $720 at Jefferies November 6, 2020 8:29 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $630 at BMO Capital November 6, 2020 8:02 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $770 at Truist Securities November 6, 2020 7:06 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $737 at Credit Suisse November 6, 2020 6:05 AM - StreetInsider Exclusive: WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir November 5, 2020 7:59 AM - StreetInsider Form 10-Q REGENERON PHARMACEUTICAL For: Sep 30 November 5, 2020 7:49 AM - SEC Filing Form 8-K REGENERON PHARMACEUTICAL For: Nov 05 November 5, 2020 7:32 AM - SEC Filing Regeneron (REGN) Tops Q3 EPS by $1.23, Revenues Beat November 5, 2020 6:50 AM - StreetInsider Regeneron Reports Third Quarter 2020 Financial and Operating Results November 5, 2020 6:30 AM - PR NewsWire Regeneron (REGN) 30-day option implied volatility flat into quarter results November 4, 2020 3:34 PM - StreetInsider Tech, health stocks rise, cyclicals fall on prospects of divided U.S. Congress November 4, 2020 7:00 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Nov 02 Filed by: RYAN ARTHUR F November 3, 2020 5:23 PM - SEC Filing 2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020 November 2, 2020 10:00 AM - BizWire Regeneron (REGN) Says REGN-COV2 IDMC Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low or No Oxygen Requirements October 30, 2020 9:13 AM - StreetInsider REGN-COV2 Independent Data Monitoring Committee Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low or No Oxygen Require October 30, 2020 9:12 AM - PR NewsWire Regeneron Once Again Earns #1 Ranking in Science Magazine's Top Biopharma Companies to Work For October 29, 2020 2:32 PM - PR NewsWire Regeneron (REGN) Said Trump-Taken COVID-19 Antibody Cocktail Cuts Viral Load, Analysts See Case for FDA Emergency Use Approval October 29, 2020 8:49 AM - StreetInsider Regeneron (REGN) Announces FDA Accepts for Priority Review Libtayo for Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50% October 29, 2020 7:57 AM - StreetInsider FDA Accepts for Priority Review Libtayo® (cemiplimab-rwlc) for Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50% October 29, 2020 7:00 AM - PR NewsWire Regeneron (REGN) weekly IV flat into REGN-COV2 met endpoints in Phase 2/3 seamless trial October 29, 2020 1:22 AM - StreetInsider Full Article List